
zzso cancer zzso requires identifying and targeting an zzso zzso present in the individual patient's tumor as compared to that patient's normal zzso Manufacturing a fully targeted zzso can be time consuming and expensive, limiting the use of targeted zzso as personalized cancer zzso An zzso zzso whether in zzso or in zzso tends to exchange a half of itself with another zzso zzso This biological characteristic creates zzso hybrids with zzso zzso It is hypothesized that this zzso characteristic can be exploited to therapeutic advantage in creating highly targeted zzso An hypothesized strategy to more easily achieve personalized zzso is to create a generic zzso zzso zzso agent, but then to use the patient's own ability to create the targeting via their zzso zzso zzso zzso zzso these two in the form of a zzso zzso zzso The manufactured half would carry the therapeutic zzso (such as a radioactive agent or a zzso and the zzso half would afford the personalized zzso zzso 

